- Ringhofer B, Polzer W, Prchal-Murphy M, Doma E, Kollmann S, Gamper E, Kendler J, Maw B, Zebedin-Brandl E, Li J, Green AR, Krauth M-T, Hadzijusufovic E, Ivanov D, Valent P, Hoermann G, Klampfl T, Sexl V, Kollmann K. (2026). CDK6 inactivation counteracts CALR-mutant-induced MPN evolution and sensitizes MPN stem cells to Interferon-α treatment. Hemasphere. 2026 May 12:10:e70363. https://doi.org/10.1002/hem3.70363
- Scheiblecker L, Klampfl T, Doma E, Nebenfuehr S, Torres-Tuesada O, Strich S, Heller G, Werdenich D, Tschulenk W, Zojer M, Bellutti F, Schirripa A, Zöchbauer-Müller S, Valent P, Walter I, Stefan E, Sexl V, Kollmann K. (2025). CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia. Cell Death Dis. 2025 Feb 18;16(1):107. https://doi.org/10.1038/s41419-025-07434-1
- Schirripa A, Schöppe H, Nebenfuehr S, Zojer M, Klampfl T, Kugler V, Maw BS, Ceylan H, Uras IZ, Scheiblecker L, Gamper E, Stelzl U, Stefan E, Kaserer T, Sexl V, Kollmann K. (2024). Cdk6's functions are critically regulated by its unique C-terminus. iScience. 2024 Dec 27;28(2):111697. doi: 10.1016/j.isci.2024.111697. eCollection 2025 Feb 21. https://doi.org/10.1016/j.isci.2024.111697
-Mayer IM, Doma E, Klampfl T, Prchal-Murphy M, Kollmann S, Schirripa A, Scheiblecker L, Zojer M, Kunowska N, Gebrail L, Shaw LE, Mann U, Farr A, Grausenburger R, Heller G, Zebedin-Brandl E, Farlik M, Malumbres M, Sexl V, Kollmann K. (2024). Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells. Blood, blood.2023021985. https://doi.org/10.1182/blood.2023021985
-Lind J, Hellinger R, Kudweis P, Moll HP, Gattringer J, Thell K, Edtmayer S, Gruber CW, Stoiber-Sakaguchi D, Kollmann K. (2022). The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma. Biomedicine & Pharmacotherapy (2022), 153. https://doi.org/10.1016/j.biopha.2022.113486
- Schmalzbauer BS, Thondanpallil T, Heller G, Schirripa A, Sperl CM, Mayer IM, Knab VM, Nebenfuehr S, Zojer M, Mueller AC, Fontaine F, Klampfl T, Sexl V, Kollmann K. (2022). CDK6 Degradation Is Counteracted by p16INK4A and p18INK4C in AML. Cancers (Basel). 2022 Mar 18;14(6):1554. https://doi.org/10.3390/cancers14061554
- Doma E, Mayer IM, Brandstoetter T, Maurer B, Grausenburger R, Menzl I, Zojer M, Hoelbl-Kovacic A, Carlsson L, Heller G, Kollmann K$, Sexl V$. (2021). A robust approach for the generation of functional hematopoietic progenitor cell lines to model leukemic transformation. Blood Adv. 2021 Jan 12;5(1):39-53. https://doi.org/10.1182/bloodadvances.2020003022
- Heller G, Nebenfuehr S, Bellutti F, Ünal H, Zojer M, Scheiblecker L, Sexl V, Kollmann K. The Effect of CDK6 Expression on DNA Methylation and DNMT3B Regulation. iScience. 2020 Oct 7;23(10):101602. https://doi.org/10.1016/j.isci.2020.101602
- Kollmann K, Warsch W, Gonzalez-Arias C, Nice FL, Avezov E, Milburn J, Li J, Dimitropoulou D, Biddie S, Wang M, Poynton E, Colzani M, Tijssen MR, Anand S, McDermott U, Huntly B, Green AR. A novel signalling screen demonstrates that CALR mutations activate essential MAPK signalling and facilitate megakaryocyte differentiation. Leukemia. 2016 Dec 2. https://doi.org/10.1038/leu.2016.280
* shared first authorship
$ shared last authorship